Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

NCT06425978 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Genitourinary Syndrome of Menopause

Interventions

DRUG: Cellular Matrix / A-CP-HA Kit
DRUG: Local estrogen therapy (Blissel, estriol 50 micrograms/g vaginal gel)

Sponsor

Fundación Santiago Dexeus Font

Collaborators

[object Object]